VE

Healthcare · Pharmaceuticals

Venus Remedies Ltd (VENUSREM)

₹1,502.00

Mkt cap
₹2,002 Cr
P/E ratio
16.40
P/B
2.85
Div yield
0.67%
ROE
15.60%
ROCE
20.70%
EPS (TTM)
₹91.59
Book value
₹527
52W range
550–2,044
Sector
Healthcare

Price history

Previous close

Incorporated in 1989, Venus Remedies Ltd is a research-based pharmaceutical company focused on complex injectable formulations across critical care, oncology, anti-infectives and specialty therapies. It operates across 100+ countries, with a product basket of 195+, 1,100+ marketing authorisations and 700+ dossiers filed.{# {# https://www.bseindia.com/xml-data/corpfiling/AttachHis/29971821-bfab-4659-a9d8-7cf5dc170d02.pdf#page=36 #} #}

NSE VENUSREMBSE 526953
Health check
Constructive
ValuationCheap
ProfitabilityStrong
GrowthModerate
TechnicalsNeutral
52-week range
−26.53% from high
₹1,502
₹550+173.09% from low₹2,044
Current
₹1,502.00
Prev close
₹1,513.00
Day
−0.73%
Price performance
1D
−0.73%
1W
+0.28%
1M
+4.20%
3M
−14.93%
6M
+45.75%
1Y
+162.66%
YTD
+92.66%

Financials

Revenue, profit & margin
P/E ratio
16.4×
VENUSREM is 52% below the sector median of 34.0×
VENUSREM16.4×
Sector median34.0×
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales168143195109170177195137193180259179219
YoY Sales growth+20%+23%+25%+14%+1%+23%-0%+26%+13%+2%+33%+30%+13%
Expenses15013117697163158166122162143196145176
Operating Profit1812191181829153138633442
OPM %11%8%10%10%4.5%10%15%11%16%21%24%19%19%
Other Income32428127323531
Interest0000000000000
Depreciation67666556677710
Profit before tax14817792531132633623033
Tax %31%12%40%82%61%21%32%24%24%24%23%24%23%
Net Profit10711142021102026482326
EPS in Rs7.445.127.860.912.6314.6615.717.1815.0619.1435.5417.1819.19
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move −4.99% · closed higher next day 0 of last 1
 Q2FY27
Broadcast26 Oct '26◦
Earnings day−4.99%
+1 day−9.00%
+5 days−10.03%
+15 days−0.47%
+30 days—
FilingXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
41.76%Promoter
Promoters41.76%
FIIs3.14%0.22
DIIs0.74%0.15
Public54.37%0.07
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,880.0036.664,51,0750.85%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹11,442.0088.893,03,7490.26%1,127+63.57%3,676+35.40%21.97%
Torrent Pharma.₹4,670.0081.821,77,6320.81%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,424.0097.751,30,9720.08%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,189.9026.201,18,6930.08%928−27.96%7,910+29.17%21.14%
Dr Reddy's Labs₹1,380.0041.171,15,2670.58%913−31.35%8,698−1.48%13.04%
Cipla₹1,391.8036.211,12,4420.93%852−35.05%7,404−2.44%15.49%
Venus Remedies₹1,497.8016.452,0020.67%26+27.42%219+13.49%20.71%
Median: 160 Co.₹465.8333.992,0120.08%13+33.53%179+20.92%14.94%

Filings